期刊文献+

托吡酯治疗癫痫49例临床观察 被引量:1

CLINICAL OBSERVATION OF TREATMENT OF EPILEPTIC WITH RUOBIZI
下载PDF
导出
摘要 目的 :观察单纯及联合应用托吡酯治疗各种类型癫痫的临床疗效、药物耐受性、用药方法、剂量及副作用。方法 :选择 4 9例癫痫病人 ,采用托吡酯单独及联合治疗。经 8周加量期和 12周稳定期观察后进行评价。结果 :总有效率 91.8%和完全控制率 71.4 %。联合治疗组与单独治疗组有效率分别为 96 .6 %和 81.3% ;控制率分别为 71.9%和 6 8.8%。结论 :托吡酯适用于成人与小儿的各种类型癫痫 ,至于选择单药治疗还是联合治疗应综合年龄、病程、基础发作频率等多种因素。副作用多为一过性 。 Objective :Observe therapy method, medicine toleration, clinical curative effect and side effect of all kinds of epileptic with toubozi. Method : Select 49 epileptic,using toubizhi by single or combined treatment .Observe after 8 weeks inhance dose phase and 12 weeks stationary phase. Result : Total effective rate is 91.8%,complete control rate is 71.4%.The effective rate of combinded treat and single treat were 96.6% and 81.3% respectively,their control rate were 71.7% and 68.8% respectively .Conclusion : Toubizi is suitable to treat all kinds of epileptic in adult and children .Treat method should be choosed according to age ,course ,basal attack rate and other factors.
出处 《牡丹江医学院学报》 2002年第6期11-14,共4页 Journal of Mudanjiang Medical University
关键词 托吡酯 癫痫 药物耐受性 副作用 基础发作率 治疗 tuobizi epileptic medicine toleration side effect basal attack rate
  • 相关文献

参考文献6

  • 1Glauser TA. Topiramate. Epilepsia,1999,40,(suppl 5):S71-S80
  • 2Reife R, Pledger G, Wu S.Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults. Epilepsia,2000,41(1):66
  • 3中国托吡酯研究协作组.托吡酯多中心开放性添加治疗成人难治性癫痫部分性发作的临床观察[J].中华神经科杂志,2001,34(3):132-134. 被引量:48
  • 4潘英,廖卫平,杨少青,何小诗,蒲蜀湘,黎冰梅,陆雪芬.托吡酯添加治疗难治性癫痫的临床研究[J].中华神经科杂志,2001,34(3):135-137. 被引量:29
  • 5Ben-Menachem E,Henrikwen O,Dam M, et al. Double-blind, placebocontrolled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia, 1996; 37:539~543
  • 6Alou-Kholil B. Topiramate YOL Study Group. Topiramate in long-term management of refractory epilepsy. Epilepsia, 2000,41 (1):72~76

二级参考文献8

  • 1Lhotoo S D,Epilepsia,2000年,41卷,338页
  • 2Reife R,Epilepsia,2000年,41卷,suppl 1期,S66页
  • 3Sharief M,Viteri C,Ben-Menachem E,et al.Double-blind, placebocontrolled study of topiramate in patients with refractory epilepsy[].Epilepsy Research.1996
  • 4Ben-Menachem E,Henriksen O,DamM,et al.Double-blind, placebocontrolled trial of topiramate as add-on therapy in patients with refractory partial seizures[].Epilepsia.1996
  • 5Tassinari CA,Michelucci R,Chauvel P,et al.Double-blind, placebocontrolled trial of topiramate ( 600 mg daily ) for the treatment of refractory partial epilepsy[].Epilepsia.1996
  • 6Glauser TA.Topiramate[].Seminars in Pediatric Neurology.1997
  • 7Faught E,Wilder BJ,Ramsay RE,et al.Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200, 400, and 600 mg daily dosages[].Neurology.1996
  • 8Privitera M,Fincham R,Penry J,et al.Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600, 800, and 1 000 mg daily dosages[].Neurology.1996

共引文献65

同被引文献3

  • 1Commission on Classification and Terminology of International League Against Epilepsy. Proposal for revised clinical and electroencephalographic classification of epileptic seizures. Epilepsia,1981,22(4) :489-501.
  • 2ORMROD D, MCCLELLAN K J. Topiramate: a review of its use in childhood epilepsy. Pediatric Drugs, ,2001,3 (4) :293 - 319.
  • 3潘松青,刘德新,张双国.新型抗癫痫药托吡酯治疗癫痫的临床研究[J].中国药房,2002,13(8):486-487. 被引量:2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部